Armen Shanafelt, Director at Aeglea BioTherapeutics, Inc. (AGLE), bought 286,484 shares at $3.67 ($1.1M) on 2021-12-09, disclosed to the SEC on 2021-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.67 | 121,799 | $447K | 42.5% |
| 2 | $3.67 | 121,799 | $447K | 42.5% |
| 3 | $3.65 | 13,516 | $49K | 4.7% |
| 4 | $3.65 | 14,685 | $54K | 5.1% |
| 5 | $3.65 | 14,685 | $54K | 5.1% |
| Total | $3.67 avg | 286,484 |
| $1.1M |
| 100% |
| Filing → |
| PTGX | BUY | 2016-08-16 | $7.0M | — | Filing → |